PubRank
Search
About
Armando Gabrielli
Author PubWeight™ 60.66
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
Arthritis Rheum
2013
5.99
2
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.
N Engl J Med
2006
4.46
3
Management of minor head injury in patients receiving oral anticoagulant therapy: a prospective study of a 24-hour observation protocol.
Ann Emerg Med
2012
3.55
4
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
Ann Rheum Dis
2013
3.11
5
Imatinib for refractory chronic graft-versus-host disease with fibrotic features.
Blood
2009
2.51
6
Regional Implantation of Autologous Adipose Tissue-Derived Cells Induces a Prompt Healing of Long-Lasting Indolent Digital Ulcers in Patients With Systemic Sclerosis.
Cell Transplant
2014
2.02
7
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.
J Rheumatol
2002
1.97
8
Risk of non-Hodgkin lymphoma in celiac disease.
JAMA
2002
1.81
9
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease.
Blood
2007
1.60
10
Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study.
Crit Care
2014
1.56
11
Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis.
Clin Exp Rheumatol
2012
1.41
12
Role of viral infections in the etiopathogenesis of systemic sclerosis.
Clin Exp Rheumatol
2013
1.40
13
Bone marrow endothelial progenitors are defective in systemic sclerosis.
Arthritis Rheum
2006
1.30
14
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.
Autoimmun Rev
2011
1.26
15
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts.
J Biol Chem
2005
1.26
16
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD.
Blood
2013
1.24
17
Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.
PLoS One
2010
1.15
18
Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
Arthritis Rheum
2002
1.10
19
Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies.
Rheumatology (Oxford)
2012
1.06
20
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise.
Arthritis Care Res (Hoboken)
2012
1.06
21
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application.
Autoimmun Rev
2010
1.03
22
Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies.
Chest
2015
1.01
23
Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias.
Arch Intern Med
2005
0.99
24
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
Autoimmun Rev
2012
0.98
25
Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis.
Arthritis Rheum
2011
0.90
26
Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis.
Autoimmun Rev
2009
0.88
27
Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody.
Neurobiol Dis
2006
0.87
28
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study.
Arthritis Res Ther
2014
0.87
29
Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study.
Clin Exp Rheumatol
2011
0.86
30
Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis.
Clin Rheumatol
2014
0.85
31
CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment.
Clin Exp Rheumatol
2012
0.84
32
Acute myocarditis associated with adenoviral infection in a patient with scleroderma.
Clin Rheumatol
2003
0.82
33
From scleredema to AL amyloidosis: disease progression or coincidence? Review of the literature.
Clin Rheumatol
2005
0.82
34
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts.
Fibrogenesis Tissue Repair
2011
0.80
35
Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA.
Immunology
2014
0.80
36
[Intravenous immunoglobulin treatment in autoimmune diseases].
Recenti Prog Med
2007
0.79
37
Stiff and tight skin: a rear window into fibrosis without inflammation.
Sci Transl Med
2010
0.79
38
Role of the HLA class II: HCV-related disorders.
Ann N Y Acad Sci
2007
0.79
39
Characterization of the c-Myb-responsive region and regulation of the human type I collagen alpha 2 chain gene by c-Myb.
J Biol Chem
2002
0.78
40
Biologic Therapy in Inflammatory and Immunomediated Arthritis: Safety Profile.
Curr Drug Saf
2016
0.77
41
Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance.
Radiol Med
2014
0.76
42
Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al.
Arthritis Rheum
2009
0.76
43
Biomechanical study of 16-mm threaded, 32-mm threaded, and fully threaded SCFE screw fixation.
J Pediatr Orthop
2011
0.76
44
Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies.
J Gen Virol
2009
0.76
45
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?'.
Autoimmun Rev
2015
0.75
46
Reply to J. Magalon et al.
Cell Transplant
2015
0.75
47
Pemphigus vulgaris is characterized by low IgG reactivities to specific self-antigens along with high IgG reactivity to desmoglein 3.
Immunology
2014
0.75
48
Influence of age and autoimmunity on liver disease in HCV-associated type II mixed cryoglobulinemia.
Hum Immunol
2002
0.75
49
[The diagnostic admission in an internal medicine service: clinical and economic aspects].
Recenti Prog Med
2007
0.75
50
[Immunosuppressant treatment in refractory myositis. Our experience].
Recenti Prog Med
2009
0.75
51
Subcutaneous immunoglobulins in ocular myositis.
Rheumatology (Oxford)
2012
0.75
52
Breast contouring in postbariatric patients: a technique selection algorithm.
Obes Surg
2010
0.75
53
Biologic Therapy in Inflammatory Immunomediated Systemic Diseases: Safety Profile.
Curr Drug Saf
2016
0.75